The orthobiologics market is expanding due to increasing cases of orthopedic disorders, advancements in regenerative medicine, and growing demand for minimally invasive treatments. Orthobiologics, including bone graft substitutes, platelet-rich plasma (PRP), and stem cell therapy, are transforming orthopedic care by enhancing bone healing and soft tissue regeneration.
Orthobiologics Market size was valued at USD 6.43 Billion in 2023 and is poised to grow from USD 6.78 Billion in 2024 to USD 10.41